Literature DB >> 8838178

A prospective clinical and bacteriologic study of inguinal buboes in Thai men.

C Viravan1, D A Dance, C Ariyarit, S Looareesuwan, Y Wattanagoon, T M Davis, V Wuthiekanun, S Tantivanich, B J Angus, N J White.   

Abstract

One-hundred thirteen men (mean age, 23 years) who presented with inguinal buboes to a government-operated hospital for sexually transmitted diseases (STDs) in Bangkok were studied between February 1987 and February 1989. The median duration of preceding symptoms was 7 days (range, 1-62 days). The majority of patients (74; 65%) had received treatment previously; 31 (27%) were febrile, 13 (12%) had extrainguinal lymphadenopathy, and 31 (27%) had concurrent active genital ulcers. There was no history of genital ulceration in 66 (58%) of the patients. Pus was obtained from 51 of the 110 buboes aspirated for culture; 21 (41%) of these cultures yielded Haemophilus ducreyi, and 2 (3.9%) were positive for Chlamydia trachomatis on immunofluorescence microscopy. Saline (1 mL) was injected and reaspirated from the buboes of 35 of the other 59 patients; 3 buboes yielded H. ducreyi and 9 were positive for C. trachomatis. All cultures for other aerobic and anaerobic bacteria and viruses in intact buboes were negative. Syphilis serology was positive in only one case. Patients attending STD clinics in this region who have large, fluctuant, edematous inguinal buboes containing pus should receive presumptive treatment for chancroid. If there is no pus, then the bubo is more likely to be caused by lymphogranuloma venereum.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8838178     DOI: 10.1093/clinids/22.2.233

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  5 in total

Review 1.  Lymphogranuloma venereum.

Authors:  D Mabey; R W Peeling
Journal:  Sex Transm Infect       Date:  2002-04       Impact factor: 3.519

Review 2.  Chancroid: clinical manifestations, diagnosis, and management.

Authors:  D A Lewis
Journal:  Sex Transm Infect       Date:  2003-02       Impact factor: 3.519

3.  Chlamydia trachomatis: genome sequence analysis of lymphogranuloma venereum isolates.

Authors:  Nicholas R Thomson; Matthew T G Holden; Caroline Carder; Nicola Lennard; Sarah J Lockey; Pete Marsh; Paul Skipp; C David O'Connor; Ian Goodhead; Halina Norbertzcak; Barbara Harris; Doug Ormond; Richard Rance; Michael A Quail; Julian Parkhill; Richard S Stephens; Ian N Clarke
Journal:  Genome Res       Date:  2007-11-21       Impact factor: 9.043

4.  Whole-genome analysis of diverse Chlamydia trachomatis strains identifies phylogenetic relationships masked by current clinical typing.

Authors:  Simon R Harris; Ian N Clarke; Helena M B Seth-Smith; Anthony W Solomon; Lesley T Cutcliffe; Peter Marsh; Rachel J Skilton; Martin J Holland; David Mabey; Rosanna W Peeling; David A Lewis; Brian G Spratt; Magnus Unemo; Kenneth Persson; Carina Bjartling; Robert Brunham; Henry J C de Vries; Servaas A Morré; Arjen Speksnijder; Cécile M Bébéar; Maïté Clerc; Bertille de Barbeyrac; Julian Parkhill; Nicholas R Thomson
Journal:  Nat Genet       Date:  2012-03-11       Impact factor: 38.330

5.  Chlamydia trachomatis L2c Infection in a Porcine Model Produced Urogenital Pathology and Failed to Induce Protective Immune Responses Against Re-Infection.

Authors:  Evelien De Clercq; Matthias Van Gils; Katelijn Schautteet; Bert Devriendt; Celien Kiekens; Koen Chiers; Wim Van Den Broeck; Eric Cox; Deborah Dean; Daisy Vanrompay
Journal:  Front Immunol       Date:  2020-10-26       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.